90 related articles for article (PubMed ID: 27246732)
41. Mammalian target of rapamycin complex 1 and cyclooxygenase 2 pathways cooperatively exacerbate endometrial cancer.
Daikoku T; Terakawa J; Hossain MM; Yoshie M; Cappelletti M; Yang P; Ellenson LH; Dey SK
Am J Pathol; 2014 Sep; 184(9):2390-402. PubMed ID: 25058027
[TBL] [Abstract][Full Text] [Related]
42. Cytosolic branched chain aminotransferase (BCATc) regulates mTORC1 signaling and glycolytic metabolism in CD4+ T cells.
Ananieva EA; Patel CH; Drake CH; Powell JD; Hutson SM
J Biol Chem; 2014 Jul; 289(27):18793-804. PubMed ID: 24847056
[TBL] [Abstract][Full Text] [Related]
43. AMPK Is Essential to Balance Glycolysis and Mitochondrial Metabolism to Control T-ALL Cell Stress and Survival.
Kishton RJ; Barnes CE; Nichols AG; Cohen S; Gerriets VA; Siska PJ; Macintyre AN; Goraksha-Hicks P; de Cubas AA; Liu T; Warmoes MO; Abel ED; Yeoh AE; Gershon TR; Rathmell WK; Richards KL; Locasale JW; Rathmell JC
Cell Metab; 2016 Apr; 23(4):649-62. PubMed ID: 27076078
[TBL] [Abstract][Full Text] [Related]
44. Discovery of Leucyladenylate Sulfamates as Novel Leucyl-tRNA Synthetase (LRS)-Targeted Mammalian Target of Rapamycin Complex 1 (mTORC1) Inhibitors.
Yoon S; Kim JH; Kim SE; Kim C; Tran PT; Ann J; Koh Y; Jang J; Kim S; Moon HS; Kim WK; Lee S; Lee J; Kim S; Lee J
J Med Chem; 2016 Nov; 59(22):10322-10328. PubMed ID: 27933890
[TBL] [Abstract][Full Text] [Related]
45. Transcriptional control of cellular metabolism by mTOR signaling.
Yecies JL; Manning BD
Cancer Res; 2011 Apr; 71(8):2815-20. PubMed ID: 21487041
[TBL] [Abstract][Full Text] [Related]
46. Non-metabolic functions of glycolytic enzymes in tumorigenesis.
Yu X; Li S
Oncogene; 2017 May; 36(19):2629-2636. PubMed ID: 27797379
[TBL] [Abstract][Full Text] [Related]
47. Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.
Toschi A; Lee E; Thompson S; Gadir N; Yellen P; Drain CM; Ohh M; Foster DA
Cancer Lett; 2010 Dec; 299(1):72-9. PubMed ID: 20805015
[TBL] [Abstract][Full Text] [Related]
48. Too little mTORC1 activity injures the liver.
Abraham RT
Cell Metab; 2014 Jul; 20(1):4-6. PubMed ID: 24988455
[TBL] [Abstract][Full Text] [Related]
49. mTORC1 Signaling Allows Cancer Cells to Escape Glycolytic Dependency.
Cancer Discov; 2016 May; 6(5):469. PubMed ID: 27056835
[TBL] [Abstract][Full Text] [Related]
50. Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal(-/-) mice.
Zhao T; Du H; Ding X; Walls K; Yan C
Oncogene; 2015 Apr; 34(15):1938-48. PubMed ID: 24882582
[TBL] [Abstract][Full Text] [Related]
51. mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function.
Donnelly RP; Loftus RM; Keating SE; Liou KT; Biron CA; Gardiner CM; Finlay DK
J Immunol; 2014 Nov; 193(9):4477-84. PubMed ID: 25261477
[TBL] [Abstract][Full Text] [Related]
52. Proline Starvation Induces Unresolved ER Stress and Hinders mTORC1-Dependent Tumorigenesis.
Sahu N; Dela Cruz D; Gao M; Sandoval W; Haverty PM; Liu J; Stephan JP; Haley B; Classon M; Hatzivassiliou G; Settleman J
Cell Metab; 2016 Nov; 24(5):753-761. PubMed ID: 27618686
[TBL] [Abstract][Full Text] [Related]
53. Critical role of mTOR in regulating aerobic glycolysis in carcinogenesis (Review).
Fan H; Wu Y; Yu S; Li X; Wang A; Wang S; Chen W; Lu Y
Int J Oncol; 2021 Jan; 58(1):9-19. PubMed ID: 33367927
[TBL] [Abstract][Full Text] [Related]
54. TRIM34 suppresses non-small-cell lung carcinoma via inducing mTORC1-dependent glucose utilization and promoting cellular death.
Zhang P; Chen Z; Li J; Mao H; Hu Y
Arch Biochem Biophys; 2024 Apr; 754():109925. PubMed ID: 38336254
[TBL] [Abstract][Full Text] [Related]
55. Combinatory approaches prevent preterm birth profoundly exacerbated by gene-environment interactions.
Cha J; Bartos A; Egashira M; Haraguchi H; Saito-Fujita T; Leishman E; Bradshaw H; Dey SK; Hirota Y
J Clin Invest; 2013 Sep; 123(9):4063-75. PubMed ID: 23979163
[TBL] [Abstract][Full Text] [Related]
56. Elevated aerobic glycolysis driven by p62-mTOR axis promotes arsenic-induced oncogenic phenotypes in human mammary epithelial cells.
Li Y; Liu J; Yao D; Guo Z; Jiang X; Zhang C; Qu L; Liu Y; Hu Y; Gao L; Wang Y; Xu Y
Arch Toxicol; 2024 May; 98(5):1369-1381. PubMed ID: 38485781
[TBL] [Abstract][Full Text] [Related]
57. A novel mechanism of mTORC1-mediated serine/glycine metabolism in osteosarcoma development.
Wang DW; Wu L; Cao Y; Yang L; Liu W; E XQ; Ji G; Bi ZG
Cell Signal; 2017 Jan; 29():107-114. PubMed ID: 27297361
[TBL] [Abstract][Full Text] [Related]
58. Semaphorin3A Exacerbates Cardiac Microvascular Rarefaction in Pressure Overload-Induced Heart Disease.
Li C; Zhao Y; Li F; Wang Z; Qiu Z; Yang Y; Xiong W; Wang R; Chen H; Xu F; Zang T; Pei Z; Wang Y; Shi B; Shen L; Ge J
Adv Sci (Weinh); 2023 Jul; 10(21):e2206801. PubMed ID: 37310417
[TBL] [Abstract][Full Text] [Related]
59. High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells.
Poulain L; Sujobert P; Zylbersztejn F; Barreau S; Stuani L; Lambert M; Palama TL; Chesnais V; Birsen R; Vergez F; Farge T; Chenevier-Gobeaux C; Fraisse M; Bouillaud F; Debeissat C; Herault O; Récher C; Lacombe C; Fontenay M; Mayeux P; Maciel TT; Portais JC; Sarry JE; Tamburini J; Bouscary D; Chapuis N
Leukemia; 2017 Nov; 31(11):2326-2335. PubMed ID: 28280275
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of mTORC1 signaling sensitizes hepatocellular carcinoma cells to glycolytic stress.
Zhao X; Jiang P; Deng X; Li Z; Tian F; Guo F; Li X; Wang S
Am J Cancer Res; 2016; 6(10):2289-2298. PubMed ID: 27822418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
